efavirenz / lamivudine / tenofovir disoproxil Oral Product
RxNorm concept 1161284, clinical dose form group (scdg).
- RxCUI
- 1161284
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1161284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
efavirenz / lamiVUDine / tenofovir disoproxil Oral Product
Related concepts
- lamivudine (IN, has ingredient)
- efavirenz (IN, has ingredient)
- tenofovir disoproxil (IN, has ingredient)
- Symfi Oral Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1161284 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1161284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1161284. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.